Cardiovascular disease is a disease with high morbidity and mortality.And the commonly used biomarkers still have insufficient sensitivity and specificity in clinical application.Therefore,more biomarkers are needed to be improve the diagnosis and treatment of related diseases in clinical practice.As a new predictor of cardiovascular disease,coceptin has been found to have high application value in the daily assessment and monitoring of cardiovascular disease,the early diagnosis of acute onset and the prediction of late endpoint events in recent years.Coceptin can better improve the risk assessment sys-tem of cardiovascular disease.
维普
万方数据